GoldBamboo.com - Knowledge is strong medicine
  

BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Crisis




Clinical Trial: BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

This study is currently recruiting patients.

Sponsored by: Bristol-Myers Squibb
Information provided by: Bristol-Myers Squibb

Purpose

The purpose of this study is to see what effect an investigational drug (BMS-354825) has on subjects who are currently in the myeloid blast phase of chronic myeloid leukemia (CML) and who are either resistant to or intolerant of imatinib mesylate. Another purpose of the study is to see what side effects this drug may have on subjects.

Condition Treatment or Intervention Phase
Chronic Myeloid Leukemia
Blast Crisis
 Drug: BMS-354825
Phase II

MedlinePlus related topics:  Cancer;   Cancer Alternative Therapy;   Leukemia, Adult Acute;   Leukemia, Adult Chronic;   Leukemia, Childhood

Study Type: Interventional
Study Design: Treatment

Official Title: A Phase II Study of BMS-354825 in Subjects with Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

  • Subjects who are eligible and willing to undergo transplantation
  • Serious uncontrolled medical disorder or active infection
  • Uncontrolled or significant heart problems, such as congestive heart failure, recent heart attack, etc.
  • Subjects receiving medications that may affect heart rhythm
  • Other malignancy/cancer other than CML
  • History of significant bleeding disorder unrelated to CML
  • Pregnant or breastfeeding women (subjects must avoid becoming pregnant)
  • Subjects received imatinib within 7 days, interferon or cytarabine within 14 days, a targeted anticancer medication within 14 days, an antineoplastic agent (other than hydroxyurea or anagrelide) within 28 days, or any other investigation medication in 28 days
  • Subject is receiving medications that affect platelet function or an anticoagulant

Location and Contact Information

BMS Call Center 1-877-526-7327      1-866-892-1BMS  Ext. 153 
BMS Call Center Outside the US and Canada      1-215-347-4079 

Alabama
      Local Institution, Birmingham,  Alabama,  United States; Recruiting

Arizona
      Local Institution, Phoenix,  Arizona,  United States; Not yet recruiting

California
      Local Institution, Los Angeles,  California,  United States; Recruiting

      Local Institution, Stanford,  California,  United States; Recruiting

      Local Institution, La Jolla,  California,  United States; Not yet recruiting

      Local Institution, Vallejo,  California,  United States; Not yet recruiting

      Local Institution, Anaheim,  California,  United States; Not yet recruiting

Colorado
      Local Institution, Denver,  Colorado,  United States; Recruiting

      Local Institution, Colorado Springs,  Colorado,  United States; Not yet recruiting

Connecticut
      Local Institution, Hartford,  Connecticut,  United States; Not yet recruiting

      Local Institution, West Haven,  Connecticut,  United States; Not yet recruiting

District of Columbia
      Local Institution, Washington,  District of Columbia,  United States; Not yet recruiting

Florida
      Local Institution, Tampa,  Florida,  United States; Not yet recruiting

      Local Institution, Jacksonville,  Florida,  United States; Not yet recruiting

Georgia
      Local Institution, Atlanta,  Georgia,  United States; Recruiting

      Local Institution, Tucker,  Georgia,  United States; Not yet recruiting

Illinois
      Local Institution, Chicago,  Illinois,  United States; Recruiting

      Local Institution, Chicago,  Illinois,  United States; Not yet recruiting

Indiana
      Local Institution, Indianapolis,  Indiana,  United States; Not yet recruiting

Iowa
      Local Institution, Iowa City,  Iowa,  United States; Not yet recruiting

Kansas
      Local Institution, Kansas City,  Kansas,  United States; Not yet recruiting

Kentucky
      Local Institution, Louisville,  Kentucky,  United States; Recruiting

      Local Institution, Lexington,  Kentucky,  United States; Not yet recruiting

Louisiana
      Local Institution, Shreveport,  Louisiana,  United States; Not yet recruiting

Maryland
      Local Institution, Baltimore,  Maryland,  United States; Not yet recruiting

Massachusetts
      Local Institution, Boston,  Massachusetts,  United States; Not yet recruiting

Michigan
      Local Institution, Detroit,  Michigan,  United States; Recruiting

Minnesota
      Local Institution, Rochester,  Minnesota,  United States; Not yet recruiting

Missouri
      Local Institution, St. Louis,  Missouri,  United States; Not yet recruiting

Nebraska
      Local Institution, Omaha,  Nebraska,  United States; Not yet recruiting

      Local Institution, Omaha,  Nebraska,  United States; Not yet recruiting

New Jersey
      Local Institution, Hackensack,  New Jersey,  United States; Recruiting

      Local Institution, New Brunswick,  New Jersey,  United States; Not yet recruiting

New Mexico
      Local Institution, Albuquerque,  New Mexico,  United States; Not yet recruiting

New York
      Local Institution, New York,  New York,  United States; Not yet recruiting

      Local Institution, Buffalo,  New York,  United States; Not yet recruiting

North Carolina
      Local Institution, Chapel Hill,  North Carolina,  United States; Not yet recruiting

      Local Institution, Durham,  North Carolina,  United States; Not yet recruiting

Ohio
      Local Institution, Columbus,  Ohio,  United States; Not yet recruiting

Oregon
      Local Institution, Portland,  Oregon,  United States; Not yet recruiting

Pennsylvania
      Local Institution, Pittsburgh,  Pennsylvania,  United States; Recruiting

Tennessee
      Local Institution, Nashville,  Tennessee,  United States; Not yet recruiting

Texas
      Local Institution, Houston,  Texas,  United States; Recruiting

      Local Institution, Dallas,  Texas,  United States; Not yet recruiting

Washington
      Local Institution, Seattle,  Washington,  United States; Not yet recruiting

Australia, New South Wales
      Local Institution, Sydney,  New South Wales,  Australia; Recruiting

Australia, Queensland
      Local Institution, South Brisbane,  Queensland,  Australia; Recruiting

Australia, South Australia
      Local Institution, Adelaide,  South Australia,  Australia; Recruiting

Australia, Victoria
      Local Institution, East Melbourne,  Victoria,  Australia; Recruiting

Australia, Western Australia
      Local Institution, Perth,  Western Australia,  Australia; Not yet recruiting

Austria
      Local Institution, Wien,  Austria; Recruiting

Belgium
      Local Institution, B-Leuven,  Belgium; Not yet recruiting

      Local Institution, Edegem,  Belgium; Not yet recruiting

      Local Institution, Yvoir,  Belgium; Not yet recruiting

      Local Institution, BRUXELLES,  Belgium; Not yet recruiting

Canada, Alberta
      Local Institution, Edmonton,  Alberta,  Canada; Not yet recruiting

Canada, British Columbia
      Local Institution, Vancouver,  British Columbia,  Canada; Not yet recruiting

Canada, Ontario
      Local Institution, Toronto,  Ontario,  Canada; Not yet recruiting

Canada, Quebec
      Local Institution, Montreal,  Quebec,  Canada; Recruiting

China
      Local Institution, Beijing,  China; Not yet recruiting

      Local Institution, Beijing,  China; Not yet recruiting

      Local Institution, Shanghai,  China; Not yet recruiting

Denmark
      Local Institution, Aarhus,  Denmark; Not yet recruiting

Finland
      Local Institution, Helsinki,  Finland; Not yet recruiting

France
      Local Institution, Poitiers cedex,  France; Recruiting

      Local Institution, Pessac,  France; Recruiting

      Local Institution, Paris Cedex 10,  France; Recruiting

      Local Institution, Lyon Cedex 03,  France; Recruiting

      Local Institution, Lille,  France; Recruiting

      Local Institution, Strasbourg Cedex,  France; Recruiting

      Local Institution, Nantes,  France; Recruiting

Germany
      Local Institution, Hamburg,  Germany; Recruiting

      Local Institution, Mainz,  Germany; Recruiting

      Local Institution, Mannheim,  Germany; Recruiting

      Local Institution, Dresden,  Germany; Not yet recruiting

      Local Institution, Leipzig,  Germany; Not yet recruiting

Hungary
      Local Institution, Budapest,  Hungary; Not yet recruiting

Ireland
      Local Institution, Dublin,  Ireland; Not yet recruiting

Ireland, Galway
      Local Institution, Co Galway,  Galway,  Ireland; Not yet recruiting

Israel
      Local Institution, RAMAT-GAN,  Israel; Recruiting

Italy
      Local Institution, Bologna,  Italy; Recruiting

      Local Institution, Roma,  Italy; Recruiting

      Local Institution, Orbassano,  Italy; Not yet recruiting

      Local Institution, Milano,  Italy; Not yet recruiting

      Local Institution, Bari,  Italy; Not yet recruiting

      Local Institution, Napoli,  Italy; Not yet recruiting

      Local Institution, Napoli,  Italy; Not yet recruiting

Korea, Republic of
      Local Institution, Seoul 150-173,  Korea, Republic of; Recruiting

      Local Institution, Seoul,  Korea, Republic of; Not yet recruiting

      Local Institution, Seoul,  Korea, Republic of; Not yet recruiting

      Local Institution, Gwangju,  Korea, Republic of; Not yet recruiting

Netherlands
      Local Institution, Rotterdam,  Netherlands; Not yet recruiting

      Local Institution, Nijmegen,  Netherlands; Not yet recruiting

Norway
      Local Institution, Trondheim,  Norway; Not yet recruiting

Philippines
      Local Institution, Quezon City,  Philippines; Not yet recruiting

Poland
      Local Institution, Warsaw,  Poland; Not yet recruiting

      Local Institution, Lodz,  Poland; Not yet recruiting

      Local Institution, Szczecin,  Poland; Not yet recruiting

      Local Institution, Wroclaw,  Poland; Not yet recruiting

      Local Institution, Lublin,  Poland; Not yet recruiting

      Local Institution, Gdansk,  Poland; Not yet recruiting

      Local Institution, Krakow,  Poland; Not yet recruiting

      Local Institution, Poznan,  Poland; Not yet recruiting

Russian Federation
      Local Institution, Moscow,  Russian Federation; Not yet recruiting

      Local Institution, St Petersburg,  Russian Federation; Not yet recruiting

      Local Institution, Moscow,  Russian Federation; Not yet recruiting

Singapore
      Local Institution, Singapore,  Singapore; Recruiting

South Africa, Free State
      Local Institution, Bloemfontein,  Free State,  South Africa; Not yet recruiting

South Africa, Gauteng
      Local Institution, Groenkloof,  Gauteng,  South Africa; Not yet recruiting

      Local Institution, PARKTOWN,  Gauteng,  South Africa; Not yet recruiting

      Local Institution, Johannesburg,  Gauteng,  South Africa; Not yet recruiting

South Africa, Western Cape
      Local Institution, Plumstead,  Western Cape,  South Africa; Not yet recruiting

Spain
      Local Institution, Barcelona,  Spain; Not yet recruiting

      Local Institution, Madrid,  Spain; Not yet recruiting

      Local Institution, Madrid,  Spain; Not yet recruiting

Sweden
      Local Institution, Uppsala,  Sweden; Recruiting

      Local Institution, Stockholm,  Sweden; Not yet recruiting

      Local Institution, GOTHENBURG,  Sweden; Not yet recruiting

      Local Institution, Lund,  Sweden; Recruiting

      Local Institution, Umea,  Sweden; Not yet recruiting

Switzerland
      Local Institution, Basel,  Switzerland; Recruiting

Taiwan, Province of China
      Local Institution, Taipei,  Taiwan, Province of China; Recruiting

      Local Institution, Taipei,  Taiwan, Province of China; Recruiting

      Local Institution, Taoyuan,  Taiwan, Province of China; Not yet recruiting

United Kingdom, Central
      Local Institution, Glasgow,  Central,  United Kingdom; Recruiting

United Kingdom, Greater London
      Local Institution, London,  Greater London,  United Kingdom; Recruiting

United Kingdom, Tyne and Wear
      Local Institution, Newcastle upon Tyne,  Tyne and Wear,  United Kingdom; Not yet recruiting

More Information

Study ID Numbers:  CA180-006
Record last reviewed:  March 2005
Last Updated:  March 31, 2005
Record first received:  January 13, 2005
ClinicalTrials.gov Identifier:  NCT00101816
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 8, 2005

Resources



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Crisis.

December 4, 2008



Page Updated: November 5, 2004
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.